Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension, October 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 168 articles: HTML format

Single Articles

1. CHANG SA
   Pulmonary Hypertension Redefined: From Historical Thresholds to Prognostic Relevance.
   Korean Circ J. 2025 Aug 13. doi: 10.4070/kcj.2025.0231.
   PubMed    
   
   
   

2. RAFALOWICZ A, Mierzejewski J, Czuba L, Lisowska A, et al
   Intensification of diuretic therapy in pulmonary hypertension - a retrospective evaluation of hemodynamic and functional changes.
   Adv Med Sci. 2025 Oct 1:S1896-1126(25)00041-0. doi: 10.1016/j.advms.2025.
   PubMed    
   Abstract available
   
   

3. SHENG Y, Min F, Wang Y, Zhang X, et al
   Crocin inhibits neutrophil migration and activation to treat hypoxic pulmonary hypertension through targeting HCK.
   Phytomedicine. 2025;148:157334.
   PubMed    
   Abstract available
   
   

4. ALESSANDRO MM, Luca R, Andrea Raffaele M, Fabrizio G, et al
   Clinical outcomes of transcatheter edge-to-edge repair in patients with functional mitral regurgitation and pulmonary hypertension.
   Eur J Clin Invest. 2025 Oct 3:e70130. doi: 10.1111/eci.70130.
   PubMed    
   Abstract available
   
   

5. KHAN I, Ishaque G, Khan AA, Shafiq F, et al
   Balloon Pulmonary Angioplasty Versus Riociguat in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
   Cardiol Rev. 2025 Oct 1. doi: 10.1097/CRD.0000000000001049.
   PubMed    
   Abstract available
   
   

6. WANG X, Wang L, Yuan Y, Zhao X, et al
   Neonatal early-onset sepsis caused by Streptococcus Gallolyticus subsp. Pasteurianus with severe pulmonary hypertension and leukemoid reaction: a case report.
   BMC Pediatr. 2025;25:699.
   PubMed    
   Abstract available
   
   

7. AY O, Gunes S, Erfidan E, Simsek A, et al
   Neonatal pulmonary hypertension in the NICU: a 10-year single-center experience.
   BMC Pediatr. 2025;25:724.
   PubMed    
   Abstract available
   
   

8. ZHANG M, Chen X, Xu Y, Chen Y, et al
   Efficacy and safety of treprostinil in pediatric pulmonary hypertension following fontan surgery: a real-world analysis.
   BMC Pediatr. 2025;25:739.
   PubMed    
   Abstract available
   
   

9. CAHYONO A, Irwanto, Rahman MA, Widjiati W, et al
   Effects of sildenafil and metformin on endothelin-1 in the progression of pulmonary hypertension.
   Open Vet J. 2025;15:3087-3096.
   PubMed    
   Abstract available
   
   

10. MECHA MH, Million L, Asefa ET
    Navigating the clinical complexity of acute heart failure in an untreated adult with dextrotransposition of the great arteries (D-TGA) and multiple cardiac anomalies: a case report and review of literature.
    J Med Case Rep. 2025;19:476.
    PubMed    
    Abstract available
    
    

11. MAHOMED AS, Burke-Gaffney A, Moledina S, Toe QK, et al
    SOX17-silenced HPAECs upregulate NF-kappaB-induced CXCL10 and CXCL11: implications for lymphocyte chemotaxis in SOX17-PAH.
    Sci Rep. 2025;15:34262.
    PubMed    
    Abstract available
    
    

12. SATO A, Sekine M, Kawasaki H, Kanai M, et al
    Optimal Therapeutic Strategy for Ventricular Septal Defect Closure in Extremely Preterm Infants with Chronic Lung Disease and Severe Pulmonary Hypertension.
    Int Heart J. 2025;66:914-919.
    PubMed    
    Abstract available
    
    

13. OTSUKA M, Sonoda S, Yamada T, Aoki S, et al
    Pulmonary Hypertension Associated with Severe Interstitial Pneumonia Successfully Treated with Inhaled Treprostinil: A Case Report.
    Intern Med. 2025 Oct 2. doi: 10.2169/internalmedicine.6206.
    PubMed    
    Abstract available
    
    

14. CAO Z, Xiao Q, Li X, Zhang H, et al
    Postmarketing analysis of sotatercept: identifying serious unlabelled events.
    Open Heart. 2025;12:e003636.
    PubMed    
    Abstract available
    
    

15. JEFFERSON L, Lima PDA, Archer SL
    Macrophage plasticity and glucose metabolism: the role of immunometabolism in pulmonary arterial hypertension.
    Clin Sci (Lond). 2025;138:CS20257363.
    PubMed    
    Abstract available
    
    

16. RUTLAND C, Hall CS, Kolaitis NA, Kulkarni T, et al
    Pulmonary Hypertension Associated with Interstitial Lung Disease: Screening and Epidemiology.
    ATS Sch. 2025 Oct 1. doi: 10.34197/ats-scholar.2024-0135.
    PubMed    
    
    
    

17. GELLER A, Martinez Manzano JM, Kosak Lopez E, Wattanachayakul P, et al
    Association of Estimated Plasma Volume Status With Invasive Hemodynamics and Adverse Clinical Outcomes in Patients With Pulmonary Hypertension and Chronic Kidney Disease.
    Pulm Circ. 2025;15:e70157.
    PubMed    
    Abstract available
    
    

18. WRAY J, Quyam S, Clisby H, Kelly V, et al
    Exploring Health-Related Quality of Life in Children With Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70161.
    PubMed    
    Abstract available
    
    

19. JAMES J, Niihori M, Varghese MV, McClain N, et al
    Mitochondrial dysfunction-induced hemolysis: a precursor to vascular leakage and pulmonary hypertension.
    Blood Vessel Thromb Hemost. 2025;2:100097.
    PubMed    
    
    
    

20. LANG JE, Hill KD
    Chronic Lung Disease-Related Pulmonary Hypertension in Children.
    Acta Paediatr. 2025 Sep 30. doi: 10.1111/apa.70320.
    PubMed    
    Abstract available
    
    

21. BEURNIER A, Lacoste-Palasset T, Jais X, Savale L, et al
    Beyond the shunt: Divergent insights from hyperoxia testing and contrast echocardiography in adults with pulmonary hypertension.
    Physiol Rep. 2025;13:e70594.
    PubMed    
    Abstract available
    
    

22. LAPOINTE A, Kipfmueller F, Patel N, Altit G, et al
    Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management.
    Neoreviews. 2025;26:e660-e678.
    PubMed    
    Abstract available
    
    

23. HACKNER D, Lange D, Grafe C, Andrassy J, et al
    [Neuraxial anesthesia procedures in the perioperative management of pulmonary hypertension : A literature review with two case reports].
    Anaesthesiologie. 2025 Sep 30. doi: 10.1007/s00101-025-01595.
    PubMed    
    Abstract available
    
    

24. ZHOU JJ, Qiao E, He ZY, Yang YC, et al
    Fibulin 5 mediates pulmonary artery smooth muscle cell dysfunction and vascular remodelling in congenital heart disease associated pulmonary arterial hypertension via TGF-beta1/PI3K/AKT signalling.
    Respir Res. 2025;26:276.
    PubMed    
    Abstract available
    
    

25. YANG Z, Lu C, Dong Z, Ji S, et al
    [Rosa laevigata Michx. inhibits pulmonary arterial smooth muscle cell proliferation in hypertension by modulating the Src-AKT1 axis].
    Nan Fang Yi Ke Da Xue Xue Bao. 2025;45:1889-1902.
    PubMed    
    Abstract available
    
    

26. HU L, Liu Z, Yu J, Yang Z, et al
    The Correlation Between NLR, RDW, and Pulmonary Hypertension in Patients With Bronchiectasis and Chronic Obstructive Pulmonary Disease Overlap Syndrome.
    Clin Respir J. 2025;19:e70128.
    PubMed    
    Abstract available
    
    

27. LONG Y, Li W, Bai Y, Zhou D, et al
    Bradycardia-Associated Pulmonary Hypertension.
    JACC Case Rep. 2025 Sep 29:105540. doi: 10.1016/j.jaccas.2025.105540.
    PubMed    
    Abstract available
    
    

28. LU A, Elsea K, Olsen DA, VanderWielen BA, et al
    Regional Anesthesia in a Cirrhotic Patient With Coagulopathy and Pulmonary Hypertension: A Case Report.
    Cureus. 2025;17:e91035.
    PubMed    
    Abstract available
    
    

29. BUDZIAK S, Kloza M, Krzyzewska A, Baranowska-Kuczko M, et al
    Can Sirtuin 1 Serve as a Therapeutic Target in Pulmonary Arterial Hypertension? A Comprehensive Review.
    Molecules. 2025;30:3740.
    PubMed    
    Abstract available
    
    

30. ZHAO Z, Li G, Ohmichi K, Li X, et al
    Lacticaseibacillus rhamnosus Probio-M9 Alters the Gut Microbiota and Mitigates Pulmonary Hypertension in a Rat Model.
    Nutrients. 2025;17:2927.
    PubMed    
    Abstract available
    
    

31. REMISZEWSKI P, Ryszkiewicz P, Baranowska-Kuczko M, Pedzinska-Betiuk A, et al
    Initial Body Weight as an Important Factor for Improving the Reliability and Translational Relevance of the Preclinical Monocrotaline-Induced Rat Pulmonary Hypertension Model.
    Int J Mol Sci. 2025;26:8916.
    PubMed    
    Abstract available
    
    

32. MUDGAL M, Bhatnagar AR, Kumar Vasudevan A, Priya Gajendiran A, et al
    The Impact of Pulmonary Hypertension on Hospitalization Risk in Adults with Respiratory Syncytial Virus Infection.
    Biomedicines. 2025;13:2272.
    PubMed    
    Abstract available
    
    

33. BORSI E, Potre C, Ionita I, Samfireag M, et al
    Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Systematic Review of Prevalence, Clinical Phenotype, and Surgical Outcomes.
    Biomedicines. 2025;13:2215.
    PubMed    
    Abstract available
    
    

34. JENSEN EA
    Bronchopulmonary dysplasia, pulmonary hypertension, and neonatal gastroesophageal reflux: Association, causation, or neither?
    Semin Perinatol. 2025 Sep 25:152158. doi: 10.1016/j.semperi.2025.152158.
    PubMed    
    Abstract available
    
    

35. YU X, Sun Y, Fu L, Xu Z, et al
    Reversed Potts Shunt and Venopulmonary Extracorporeal Membrane Oxygenation Support in Sustained Pulmonary Hypertension Crisis.
    JACC Case Rep. 2025;30:105153.
    PubMed    
    Abstract available
    
    

36. SALAKO O, Singh A
    Right Ventricular Phenotyping Can Lead to Pulmonary Vascular Therapy Response in Those with Pulmonary Hypertension with COPD: A Single-Center Cohort Study.
    J Cardiovasc Dev Dis. 2025;12:366.
    PubMed    
    Abstract available
    
    

37. LIN K, Sarnari R, Gordon DZ, Markl M, et al
    Cine MRI-Derived Radiomics for the Detection of Functional Tricuspid Regurgitation in Pulmonary Hypertension: A Proof-of-Concept Study.
    J Cardiovasc Dev Dis. 2025;12:353.
    PubMed    
    Abstract available
    
    

38. GARRY JD, Kundu S, Alcorn C, Eden S, et al
    Glucagon-like Peptide 1 Receptor Agonists and Risk of Pulmonary Hypertension.
    medRxiv [Preprint]. 2025 Sep 19:2025.09.18.25336100.
    PubMed    
    Abstract available
    
    

39. LACHANT D, Agarwal N, Norton K, Haight D, et al
    Sensor Estimated Home 6-Minute Walk Distance and Cardiac Effort in Pulmonary Hypertension and Heart Failure.
    medRxiv [Preprint]. 2025 Sep 19:2025.09.18.25336075.
    PubMed    
    Abstract available
    
    

40. QUYAM S, Baker A, Calder A, Moledina S, et al
    Porto-Pulmonary Hypertension in Children: Insights From a National Registry.
    Pulm Circ. 2025;15:e70133.
    PubMed    
    Abstract available
    
    

41. THOMAS C, Chandel A, Zineddin M, Tang C, et al
    The effect of antifibrotics on the progression of pulmonary hypertension in patients with interstitial lung disease listed for lung transplantation.
    BMC Pulm Med. 2025;25:428.
    PubMed    
    Abstract available
    
    

42. ZHANG Y, Wu L, Dong L
    Breviscapine attenuates pulmonary vascular dysfunction and inflammatory injury in a rat model of acute pulmonary embolism.
    Pak J Pharm Sci. 2025;38:1889-1897.
    PubMed    
    Abstract available
    
    

43. ULLRICH FTH, Thaler MB, Schulze-Koops H
    Telangiectasias as a Forerunner of Pulmonary Hypertension.
    Dtsch Arztebl Int. 2025;122:507.
    PubMed    
    
    
    

44. MA Q, Liu HL, Wang WW
    Pulmonary hypertension causing uveal effusion syndrome: a case report.
    Int J Ophthalmol. 2025;18:2007-2010.
    PubMed    
    
    
    

45. MICHEL H, Ozkan E, Chin-Cheong K, Badura A, et al
    Automated detection of neonatal pulmonary hypertension in echocardiograms with a deep learning model.
    Pediatr Res. 2025 Sep 24. doi: 10.1038/s41390-025-04404.
    PubMed    
    Abstract available
    
    

46. NOPP S, Spielvogel C, Bikdeli B, Alberich-Conesa A, et al
    A machine learning approach to identify patients at risk for long-term consequences after pulmonary embolism.
    Sci Rep. 2025;15:32744.
    PubMed    
    Abstract available
    
    

47. ALIKHAN R, Howard LS, Johnson M, Sweeney S, et al
    Practical guide to management after an acute pulmonary embolism.
    BMJ Open Respir Res. 2025;12:e003028.
    PubMed    
    Abstract available
    
    

48. JIANG H, Gao H, Wang D, Zeng Q, et al
    Interpretable Machine Learning Model for Pulmonary Hypertension Risk Prediction: Retrospective Cohort Study.
    JMIR Med Inform. 2025;13:e74117.
    PubMed    
    Abstract available
    
    

49. BISHARA JA, Evers P
    Pre-existing pulmonary arterial hypertension decompensation associated with e-cigarettes in an adolescent.
    Cardiol Young. 2025;35:1959-1961.
    PubMed    
    Abstract available
    
    

50. SITBON O, Sahay S, Escribano Subias P, Zolty RL, et al
    Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.
    Adv Ther. 2025;42:5104-5123.
    PubMed    
    Abstract available
    
    

51. FATHI M, Zarrinkavyani K, Biranvand Z, Abd MAA, et al
    Effect of phloretin on antioxidant status, inflammatory cytokines, blood and biochemical indices, cecal microbial load, and growth performance in broiler chickens subjected to pulmonary arterial hypertension.
    Poult Sci. 2025;104:105265.
    PubMed    
    Abstract available
    
    

52. MOLSTROM S, Beske RP, Grand J, Obling LER, et al
    Effect of oxygen targets on pulmonary hemodynamics after out-of-hospital cardiac arrest - A sub-study of the BOX cardiac arrest trial.
    Resuscitation. 2025;215:110680.
    PubMed    
    Abstract available
    
    

53. VERMAUT A, Aerts G, Willems L, Geudens V, et al
    Pulmonary arteriole narrowing in end-stage cystic fibrosis lungs occurs with and without small airway disease.
    J Cyst Fibros. 2025;24:946-953.
    PubMed    
    Abstract available
    
    

54. ATESLI YAZICI A, Memic Sancar K, Kahraman S, Bulut U, et al
    Evaluation of the acute effects of inhaled iloprost on aortic compliance in pulmonary arterial hypertension using invasive methods.
    Herz. 2025;50:385-394.
    PubMed    
    Abstract available
    
    

55. CHIA KSW, Carland JE, Brown K, Kotlyar E, et al
    "A new realization of what I'm able to do": exercise interventions can impact knowledge, confidence and daily activity for people with pulmonary arterial hypertension (PAH).
    Disabil Rehabil. 2025 Feb 24:1-10. doi: 10.1080/09638288.2025.2469777.
    PubMed    
    Abstract available
    
    

56. IWASA T, Inuzuka R, Ono H, Sugitani Y, et al
    Safety and Efficacy of Selexipag for Pediatric Pulmonary Arterial Hypertension in Japanese Patients?- An Open-Label Phase 2 Study.
    Circ J. 2025;89:1701-1708.
    PubMed    
    Abstract available
    
    

57. SHAO C, Xia W, Liu Y
    Bioinformatic Analysis and Molecular Docking Identify Isorhamnetin Is a Candidate Compound in the Treatment of Pulmonary Artery Hypertension.
    Anatol J Cardiol. 2025;29:52-65.
    PubMed    
    Abstract available
    
    

58. XUE X, Zhang M, Xiao Y, Guo W, et al
    [Clinical application advances of exercise right heart catheterization in the diagnosis and prognosis evaluation of pulmonary vascular diseases].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:965-969.
    PubMed    
    Abstract available
    
    

59. BLANCO I, Torres-Castro R, Piccari L, Garcia AR, et al
    Effects of pulmonary arterial hypertension therapies on arterial oxygenation in patients with pulmonary hypertension associated with lung disease: a systematic review and meta-analysis.
    BMJ Open Respir Res. 2025;12:e003086.
    PubMed    
    Abstract available
    
    

60. DARDI F, Bertozzi R, Ballerini A, Cennerazzo F, et al
    Phenotyping of patients with mild pulmonary hypertension.
    Open Heart. 2025;12:e003591.
    PubMed    
    Abstract available
    
    

61. INCI E, Ozuynuk-Ertugrul AS, Ekici B, Koseoglu-Buyukkaya P, et al
    Evaluation of Gene and microRNA Expression Patterns in Idiopathic Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension as Rare Diseases.
    Respir Med. 2025 Oct 8:108415. doi: 10.1016/j.rmed.2025.108415.
    PubMed    
    Abstract available
    
    

62. ZOU X, Cai A, Cheng Y, Li X, et al
    An integrated study on the role and underlying mechanism of QingFei Oral solution in pulmonary hypertension.
    Phytomedicine. 2025;148:157311.
    PubMed    
    Abstract available
    
    

63. CHEMLA D, Beurnier A, Gerges C, Jais X, et al
    Pulmonary arterial stiffness as the main correlate of effective arterial elastance in pre- and post-capillary pulmonary hypertension.
    Respir Med Res. 2025;88:101204.
    PubMed    
    Abstract available
    
    

64. KAUR J, Kaur G, Kaur C, Kumar S, et al
    Targeted nanosponge-based treatment for pulmonary hypertension: A novel approach.
    J Food Drug Anal. 2025;33:213-223.
    PubMed    
    Abstract available
    
    

65. ZAZZERON L, Shimoda K, Lichtenegger P, Moore E BS, et al
    Prolonged Postnatal Hypoxia Impairs Lung Development and Causes Severe Pulmonary Hypertension in Mice.
    J Am Heart Assoc. 2025 Oct 9:e042608. doi: 10.1161/JAHA.125.042608.
    PubMed    
    Abstract available
    
    

66. YAMADA K, Yaoita N, Satoh T, Yamamoto S, et al
    Long-Term Prognostic and Hemodynamic Outcomes of Intensive Immunosuppressive Therapy in Patients With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
    Int J Rheum Dis. 2025;28:e70431.
    PubMed    
    Abstract available
    
    

67. LAHM T
    What I Learned From the Study of Sex Differences in Pulmonary Hypertension: How Following the Data and the Kindness of Strangers Helped Me Overcome Self-Doubt and Imposter Syndrome.
    Pulm Circ. 2025;15:e70168.
    PubMed    
    
    
    

68. VENUGOPAL V, Karmakar S, Yadav RK, Wani AR, et al
    An Unusual Initial Manifestation of Pulmonary Embolism: Aseptic Cavitary Infarction With Pulmonary Hypertension-Case Report and Literature Review.
    Respirol Case Rep. 2025;13:e70372.
    PubMed    
    Abstract available
    
    

69. CHEN D, Tian D, Jin Q, Zhang L, et al
    The potential of non-invasive remote dielectric sensing in predicting short-term prognosis of patients with pulmonary hypertension.
    BMC Pulm Med. 2025;25:460.
    PubMed    
    Abstract available
    
    

70. ZHU F, Zhang Y, Liang G, Nan J, et al
    Diagnosis of Pulmonary Hypertension by Integrating Multimodal Data with a Hybrid Graph Convolutional and Transformer Network.
    J Imaging Inform Med. 2025 Oct 8. doi: 10.1007/s10278-025-01705.
    PubMed    
    Abstract available
    
    

71. TORBIC H, Tonelli AR
    Navigating Options for Inhaled Treprostinil Therapy in Pulmonary Hypertension.
    Respir Med. 2025 Oct 6:108398. doi: 10.1016/j.rmed.2025.108398.
    PubMed    
    
    
    

72. SHIMIZU D, Miyoshi K, Yamamoto H, Tanaka S, et al
    Survival and functional outcomes of single lung transplantation in secondary pulmonary hypertension.
    Respir Investig. 2025;63:1235-1242.
    PubMed    
    Abstract available
    
    

73. MONTANEZ-AGUIRRE AA, Flores-Guerra JM, Obregon-Rosas S, Aranda-Fraustro A, et al
    Group 4 pulmonary hypertension due to choriocarcinoma after molar pregnancy: case report and review.
    Arch Cardiol Mex. 2025 Oct 8. doi: 10.24875/ACM.25000142.
    PubMed    
    Abstract available
    
    

74. SANTOS NZF, Amaral CCL, Oliveira MVM, Delgado MA, et al
    Anesthetic Management of Elective Cesarean Delivery in a Pregnant Patient With Dilated Cardiomyopathy and Pulmonary Hypertension: A Multidisciplinary Approach.
    AANA J. 2025;93:375-378.
    PubMed    
    Abstract available
    
    

75. MICKAEL C, Kumar R, Fonseca Balladares DC, Nolan K, et al
    Role of conventional dendritic cells in schistosomiasis-induced pulmonary hypertension.
    Clin Sci (Lond). 2025 Oct 1:CS20256896. doi: 10.1042/CS20256896.
    PubMed    
    Abstract available
    
    

76. IKEDA M, Yamasaki Y, Sagiyama K, Hosokawa K, et al
    Quantitative Evaluation of Lung Perfusion by Dynamic Chest Radiography in Chronic Thromboembolic Pulmonary Hypertension: Comparison With Lung Perfusion Scintigraphy.
    Pulm Circ. 2025;15:e70170.
    PubMed    
    Abstract available
    
    

77. HUNTGEBURTH M, Kaemmerer-Suleiman AS, Hager A, Lammers AE, et al
    [Pulmonary Hypertension in Adults with Congenital Heart Disease (ACHD) - Novel Aspects from the 7th World Symposium on Pulmonary Hypertension 2024].
    Pneumologie. 2025;79:831-842.
    PubMed    
    Abstract available
    
    

78. APITZ C, Lammers AE, Hager A, Uebing A, et al
    [Pulmonary Hypertension in Childhood - An Update from the World Symposium on Pulmonary Hypertension 2024].
    Pneumologie. 2025;79:819-830.
    PubMed    
    Abstract available
    
    

79. WIEDENROTH CB, Bikou O, von Bonin S, Halank M, et al
    [Chronic Thromboembolic Pulmonary Hypertension].
    Pneumologie. 2025;79:808-818.
    PubMed    
    Abstract available
    
    

80. YOGESWARAN A, Skowasch D, Foris V, Wilkens F, et al
    [Pulmonary Hypertension Associated with Lung Diseases].
    Pneumologie. 2025;79:797-807.
    PubMed    
    Abstract available
    
    

81. SCHMIDT KH, Adler J, Bikou O, Felgendreher R, et al
    [Pulmonary Hypertension Associated with Left Heart Disease].
    Pneumologie. 2025;79:787-796.
    PubMed    
    Abstract available
    
    

82. GRUNIG E, Milger K, Omlor A, Florea A, et al
    [Treatment Algorithm of Pulmonary Arterial Hypertension].
    Pneumologie. 2025;79:775-786.
    PubMed    
    Abstract available
    
    

83. LICHTBLAU M, Harutyunova S, Klose H, von Bonin S, et al
    [General Measures and Management of PAH in Special Conditions].
    Pneumologie. 2025;79:762-774.
    PubMed    
    Abstract available
    
    

84. OLSCHEWSKI H, Barnikel M, Pittrow D, Schwaiblmair M, et al
    [Risk Stratification and Treatment Goals for Pulmonary Arterial Hypertension].
    Pneumologie. 2025;79:751-761.
    PubMed    
    Abstract available
    
    

85. PFEUFFER-JOVIC E, Schmidt KH, John T, Kramer T, et al
    [Emerging Multimodality Imaging Techniques for the Pulmonary Circulation].
    Pneumologie. 2025;79:741-750.
    PubMed    
    Abstract available
    
    

86. PFEUFFER-JOVIC E, Schmidt KH, John T, Kramer T, et al
    [Diagnostic Algorithm for Pulmonary Hypertension].
    Pneumologie. 2025;79:732-740.
    PubMed    
    Abstract available
    
    

87. DOUSCHAN P, Kaemmerer-Suleiman AS, Egenlauf B, Seyfarth HJ, et al
    [Definition and Classification of Pulmonary Hypertension].
    Pneumologie. 2025;79:723-731.
    PubMed    
    Abstract available
    
    

88. TELLO K, Kremer N, Rieth AJ, Bikou O, et al
    [Pathophysiology of the Right Ventricle and its Pulmonary Vascular Interaction].
    Pneumologie. 2025;79:712-722.
    PubMed    
    Abstract available
    
    

89. EICHSTAEDT CA, Olschewski A, Harbaum L, Cordes S, et al
    [Pathobiology and Genetics].
    Pneumologie. 2025;79:701-711.
    PubMed    
    Abstract available
    
    

90. GRUNIG E, Eichstaedt CA, Benjamin N
    [Innovations in the Field of Pulmonary Hypertension - Critical Assessment of the Results of the 7th World Symposium on Pulmonary Hypertension].
    Pneumologie. 2025;79:699-700.
    PubMed    
    Abstract available
    
    

91. LIU BY, Hu EC, Xue L, Wu WC, et al
    Electrical-mechanical dyssynchrony in pre-capillary pulmonary hypertension.
    Herz. 2025 Oct 6. doi: 10.1007/s00059-025-05343.
    PubMed    
    Abstract available
    
    

92. ZHANG Y, Zhang M, Li T, Liu Y, et al
    Emodin Alleviates Monocrotaline-Induced Pulmonary Arterial Hypertension by Directly Targeting TAK1.
    Drug Des Devel Ther. 2025;19:8843-8864.
    PubMed    
    Abstract available
    
    

93. IGARASHI-SUGIMOTO A, Tsujino I, Shima H, Nakamura J, et al
    Pathological features of pulmonary vasculopathy in interstitial lung disease-associated pulmonary hypertension.
    Respir Med. 2025 Oct 3:108395. doi: 10.1016/j.rmed.2025.108395.
    PubMed    
    Abstract available
    
    

94. SALIBE-FILHO W, Nascimento YPP, Tatagiba LS, Aiello VD, et al
    Use of direct anticoagulants in chronic thromboembolic pulmonary hypertension: An anatomopathological study of endarterectomy material.
    Int J Cardiol. 2025;443:133951.
    PubMed    
    Abstract available
    
    

95. ISLAM T, Hooper J, Zhang X, Garcia C, et al
    A soft-stiff patterned bioengineering model reveals kinase pathways driving directional cell migration in pulmonary arterial hypertension.
    Biomater Sci. 2025;13:5671-5684.
    PubMed    
    Abstract available
    
    

96. LIU J, Liu J, Qiao Y, Zhong H, et al
    Rhodiola crenulata extract inhibits cell pyroptosis to ameliorate pulmonary vascular remodeling in rats through the regulation of decadienylcarnitine/NLRP3/GSDMD axis.
    J Ethnopharmacol. 2026;354:120439.
    PubMed    
    Abstract available
    
    

97. NAKAYAMA Y, Eguchi S
    The renin-angiotensin system in models of pulmonary arterial hypertension vs primary hypertension.
    Hypertens Res. 2025;48:2522-2526.
    PubMed    
    Abstract available
    
    

98. JUNQI G, Chaohui L, Fengyou Y, Wei C, et al
    Pulmonary Artery Denervation for Idiopathic Pulmonary Arterial Hypertension: A Case Report.
    Catheter Cardiovasc Interv. 2025;106:2218-2223.
    PubMed    
    Abstract available
    
    

99. CARBONERA S, Scelsi L, Greco A, Schirinzi S, et al
    Pulmonary Arterial Hypertension Onset in an Adult Woman With a TBX4 Likely Pathogenic Variant Following Imatinib Administration: A Case Report.
    Am J Med Genet A. 2025;197:e64178.
    PubMed    
    Abstract available
    
    

100. ANTIGNY F, Crottes D, Vandier C, Capuano V, et al
     Pulmonary arterial hypertension and cancer: exploring their resemblance as channelopathies.
     Trends Mol Med. 2025;31:936-954.
     PubMed    
     Abstract available
     
     

101. HUANG H, Hu C, Zhang R, Xu H, et al
     Global Burden of Pulmonary Arterial Hypertension and Associated Heart Failure: Global Burden of Disease 2021 Analysis.
     JACC Heart Fail. 2025;13:102385.
     PubMed    
     Abstract available
     
     

102. KARGIN T, Bulbuloglu S
     The Role Competence of Cardiovascular and Respiratory Nurses Regarding Pulmonary Hypertension: A Cross-Sectional Study.
     Pulm Circ. 2025;15:e70173.
     PubMed    
     Abstract available
     
     

103. EBRAHIMI BS, Khwaounjoo P, Chan HF, Argus F, et al
     Patient-Specific Haemodynamic Modeling to Estimate the Extent of Microvascular Disease and Response to Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.
     Pulm Circ. 2025;15:e70176.
     PubMed    
     Abstract available
     
     

104. LI H, Wang Y, Zhang Y, Chen X, et al
     Transthoracic Ultrasound with Microbubble Therapy Modulates Gut Microbiota and Protects Against Hypoxia-Induced Pulmonary Hypertension in Mice.
     J Appl Microbiol. 2025 Oct 16:lxaf255. doi: 10.1093.
     PubMed    
     Abstract available
     
     

105. CORREALE M, Mercurio V, Bevere EML, Pezzuto B, et al
     Pathophysiology of Pulmonary Arterial Hypertension: Focus on Vascular Endothelium as a Potential Therapeutic Target.
     Int J Mol Sci. 2025;26:9631.
     PubMed    
     Abstract available
     
     

106. MCGANN KC, Wang CC, Trahanas JM, Bommareddi S, et al
     The Surgical Management of Chronic Thromboembolic Pulmonary Hypertension.
     J Clin Med. 2025;14:6862.
     PubMed    
     Abstract available
     
     

107. BRAILLON A, Patural P, Laville D, Perros F, et al
     Uncommon Cause of Pulmonary Hypertension: Imaging Diagnosis of Cardiac Myxoma Embolism.
     Diagnostics (Basel). 2025;15:2420.
     PubMed    
     Abstract available
     
     

108. BENJAMIN N, Schiffer V, Grunig E
     Reply to "Could Sex Differences Refine Risk Stratification in Pulmonary Hypertension?".
     J Am Soc Echocardiogr. 2025 Oct 13:S0894-7317(25)00588.
     PubMed    
     
     
     

109. CHHABRIA MS, Manek G, Persaud PN, Ennala S, et al
     Utility of Inhaled Nitric Oxide Vasoreactivity Challenge in Pulmonary Hypertension Associated with Interstitial Lung Disease.
     Ann Am Thorac Soc. 2025 Oct 15. doi: 10.1513/AnnalsATS.202502.
     PubMed    
     Abstract available
     
     

110. ALTURAIF N, Alduraibi FK
     CTD-PAH: an updated practical approach to screening, diagnosis, and management.
     Ther Adv Respir Dis. 2025;19:17534666251385674.
     PubMed    
     Abstract available
     
     

111. LU Y, Zhang J, Lan T, He J, et al
     Global, regional, and national burden of pulmonary arterial hypertension from 1990 to 2021.
     Medicine (Baltimore). 2025;104:e44933.
     PubMed    
     Abstract available
     
     

112. LI Q, Yu H, Xiong C, Gu Q, et al
     Pulmonary arterial compliance as a long-term prognostic indicator in pulmonary arterial hypertension associated with adult congenital heart disease: results from a National multicenter prospective registry.
     BMC Cardiovasc Disord. 2025;25:739.
     PubMed    
     Abstract available
     
     

113. LI J, Shen Y, Qiu X, Lin X, et al
     Combined Inhibition of FABP4/5 Ameliorates Pulmonary Hypertension by Reducing Pulmonary Vascular and Right Ventricular Fibrosis.
     Am J Respir Cell Mol Biol. 2025 Oct 14. doi: 10.1165/rcmb.2024-0352.
     PubMed    
     Abstract available
     
     

114. SARI A, Temiz Karadag D, Erdogan M, Yayla ME, et al
     Screening for Pulmonary Hypertension in Connective Tissue Diseases: Literature Review and Multidisciplinary Consensus Statement.
     Anatol J Cardiol. 2025 Oct 14. doi: 10.14744/AnatolJCardiol.2025.5301.
     PubMed    
     Abstract available
     
     

115. LIN L, Shen B, Cui J, Gao Y, et al
     Enhancing Quercetin's Potential: A Nanoliposome Delivery System for High Altitude Pulmonary Edema.
     Drug Des Devel Ther. 2025;19:9151-9167.
     PubMed    
     Abstract available
     
     

116. LUO G, Liu H, Li Z, Ji Z, et al
     A multimodal multipath AI system for assessing PAH after VSD correction on echocardiography and chest radiography images.
     Sci Rep. 2025;15:35676.
     PubMed    
     Abstract available
     
     

117. MIHAI A, Recchioni T, Manzi G, Vizza CD, et al
     Could Sex Differences Refine Risk Stratification in Pulmonary Hypertension?
     J Am Soc Echocardiogr. 2025 Oct 11:S0894-7317(25)00587.
     PubMed    
     
     
     

118. CAETANO MG, Silveira GF, Guillarducci VT, Delgado MA, et al
     Use of Combination of Nitric Oxide and Sildenafil in the Management of Severe Pulmonary Hypertension in Mitral Valve Replacement: A Case Report.
     Ann Card Anaesth. 2025;28:511-513.
     PubMed    
     
     
     

119. QIN D, Yang S, Lin L, Lin D, et al
     Clinical research on echocardiographic screening for pulmonary hypertension: TRV >2.8 m/s and mPAP >20 mmHg.
     Quant Imaging Med Surg. 2025;15:9792-9804.
     PubMed    
     Abstract available
     
     

120. BATTILANA B, Mengers J, Lang G, Haberecker M, et al
     Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension after bilateral lung transplantation.
     JHLT Open. 2025;10:100385.
     PubMed    
     Abstract available
     
     

121. MA W, Ma Y, Bai Y, Guo C, et al
     TGF-beta-Smad2/3 signaling in high-altitude pulmonary hypertension in rats: Role and mechanisms via macrophage M2 polarization.
     Open Med (Wars). 2025;20:20251279.
     PubMed    
     Abstract available
     
     

122. RIOU M, Canuet M, Hirschi S, Turquier S, et al
     Acute hemodynamic response to inhaled treprostinil in pulmonary hypertension associated with interstitial lung disease: a case highlighting unresolved questions.
     Respir Med Res. 2025;88:101210.
     PubMed    
     
     
     

123. SUN L, Li H, Li Y, Li X, et al
     Proteomic insights into platelet dysregulation and pathogenic mechanisms of chronic thromboembolic pulmonary hypertension.
     J Transl Med. 2025;23:1074.
     PubMed    
     Abstract available
     
     

124. SEMENKOVA G, Adzerikho I, Vladimirskaja T, Amaegberi N, et al
     Essential role of neutrophils in the monocrotaline-induced pulmonary arterial hypertension in rats.
     Biochem Biophys Res Commun. 2025;785:152643.
     PubMed    
     Abstract available
     
     

125. WANG X, Guo Q
     Targeting Ferroptosis Alleviates Pulmonary Arterial Hypertension, Insights from Transcriptomic and Experimental Analyses.
     Adv Biol (Weinh). 2025;9:e00001.
     PubMed    
     Abstract available
     
     

126. SU T, Tang Y, Liu Z, Hou L, et al
     Resistant Secondary Hypertension and Severe Pulmonary Hypertension in a Young Adult due to a Rare Cause.
     Clin Case Rep. 2025;13:e71174.
     PubMed    
     Abstract available
     
     

127. FAN E, Ma J, Zhang Y, Yang B, et al
     Diagnosis model for assessing chronic thromboembolic pulmonary hypertension in high-altitude pulmonary embolism patients: a machine learning approach.
     Front Med (Lausanne). 2025;12:1666574.
     PubMed    
     Abstract available
     
     

128. COLIN-ORTIZ JL, Zuniga-Gordillo R, Perez-Perez LF, Balcazar-Ochoa C, et al
     Successful percutaneous closure of ventricular septal defects associated with pulmonary hypertension using different atrial septal defect Occluders: A report of two cases.
     J Cardiol Cases. 2025;32:171-174.
     PubMed    
     Abstract available
     
     

129. DOYLE R, Wilkinson M
     Isolated Pulmonary Regurgitation without Right Heart Remodeling or Pulmonary Hypertension.
     Am J Case Rep. 2025;26:e949786.
     PubMed    
     Abstract available
     
     

130. GUAN M, Yang X, Fu L, Zhao X, et al
     Factors affecting patient outcomes in pulmonary artery thromboendarterectomy under deep hypothermic circulatory arrest and cardiopulmonary bypass support----a single center's experience.
     BMC Cardiovasc Disord. 2025;25:760.
     PubMed    
     Abstract available
     
     

131. WEN W, Gong YQ, Liu H, Su ZC, et al
     Adipose Mesenchymal Stem Cells Overexpressing Chemokine (CXCL6) Showed Strong Angiogenesis and Anti-Inflammatory Ability in the Treatment of Pulmonary Hypertension.
     Tohoku J Exp Med. 2025 Oct 23. doi: 10.1620/tjem.2025.
     PubMed    
     
     
     

132. GHANI H, Thillai M, Jenkins D, Bussell E, et al
     Pulmonary Blood Volumes on CT Predict Residual Pulmonary Hypertension Post-Pulmonary Endarterectomy.
     Am J Respir Cell Mol Biol. 2025 Oct 22. doi: 10.1165/rcmb.2025-0121.
     PubMed    
     Abstract available
     
     

133. GONG X, Sheng Y, Zhang G, Kang S, et al
     Notoginsenoside R1 Improved Hypoxic Pulmonary Hypertension by Inhibiting Glycolysis-Mediated Pulmonary Arterial Vascular Remodeling.
     Can Respir J. 2025;2025:2884885.
     PubMed    
     Abstract available
     
     

134. GUO J, Zhao J, Wang J, Li Y, et al
     Impact of Lipid Profile Alterations on the Right Heart Function and Prognosis in Pre-Capillary Pulmonary Hypertension Patients: A Prospective Cohort Study.
     Respirology. 2025 Oct 21. doi: 10.1002/resp.70145.
     PubMed    
     Abstract available
     
     

135. JIANG ML, Yang YY, Li MY, Jiang XY, et al
     Hypoxia promotes mitochondrial biogenesis in myocardium of broiler with pulmonary hypertension syndrome through AMPK/PGC-1 alpha pathway.
     Res Vet Sci. 2025;197:105941.
     PubMed    
     Abstract available
     
     

136. GUIMARAES-ERVILHA LO, Iasbik-Lima T, Soares LL, Faria JVL, et al
     Effect of pulmonary arterial hypertension on the morphology and antioxidant defence of the ventral prostate of sedentary and exercised rats.
     Int J Exp Pathol. 2025;106:e70007.
     PubMed    
     Abstract available
     
     

137. SRINIVAS S, Kotinatot S, Janjua D, Alsaqban HQH, et al
     High-output cardiac failure and severe pulmonary hypertension due to congenital hepatic hemangioma: a case report.
     Pan Afr Med J. 2025;51:100.
     PubMed    
     Abstract available
     
     

138. NAKANISHI H
     From pulmonary to ocular protection: rethinking inhaled nitric oxide in preterm infants with pulmonary hypertension.
     Pediatr Res. 2025 Oct 20. doi: 10.1038/s41390-025-04532.
     PubMed    
     Abstract available
     
     

139. BUDHRAM B, Chung S, Humbert M, Horn E, et al
     Contemporary Treatment Strategies in Pulmonary Hypertension: A Clinician's Guide.
     Annu Rev Med. 2025 Oct 20. doi: 10.1146/annurev-med-042623-013335.
     PubMed    
     Abstract available
     
     

140. HU S, Jiang J, Wang J, Li Q, et al
     Transcriptome analysis identifies upregulation of GBP4 in sarcoidosis and pulmonary hypertension.
     Chin Med J Pulm Crit Care Med. 2025;3:218-220.
     PubMed    
     
     
     

141. HUNG CT, Wang J
     Temporal bias and residual confounding obscure the association between SGLT2 inhibitor use and improved clinical outcomes in pulmonary hypertension patients.
     Ther Adv Respir Dis. 2025;19:17534666251388797.
     PubMed    
     
     
     

142. HUANG B, Hao Y, Wen Z, Dong J, et al
     Role of lipid droplets in pulmonary arterial hypertension: focusing on pulmonary artery smooth muscle cell proliferation.
     Lipids Health Dis. 2025;24:333.
     PubMed    
     Abstract available
     
     

143. SCHRAMM H, Steringer-Mascherbauer R, Mascherbauer J
     Intravenous Treprostinil in Precapillary and Postcapillary Pulmonary Hypertension Due to Cardiac Amyloidosis and Aortic Stenosis.
     JACC Case Rep. 2025;30:105474.
     PubMed    
     Abstract available
     
     

144. LEONE G, Ucakar B, Perros F, Frederick R, et al
     Synthesis and in vitro evaluation of polyethylene glycol-treprostinil conjugates for sustained local delivery in pulmonary arterial hypertension.
     Eur J Pharm Sci. 2025;214:107287.
     PubMed    
     Abstract available
     
     

145. CARMONA SEGOVIA ADM, Becerra-Munoz VM, Jimenez Arjona MJ, Naranjo Velasco V, et al
     Real-life use of validated quality of life questionnaires in patients with pulmonary arterial hypertension in Spain: a cross-sectional study.
     Eur J Cardiovasc Nurs. 2025;24:1172-1174.
     PubMed    
     Abstract available
     
     

146. MA JI, Owunna N, Mounsey LA, Jiang NM, et al
     Sex Differences in Pulmonary Hypertension and Associated Right Ventricular Dysfunction.
     Am J Cardiol. 2025 Oct 1:S0002-9149(25)00600.
     PubMed    
     Abstract available
     
     

147. TABI M, Padkins M, Bushari LI, Thaden J, et al
     Echocardiographic Predictors of Mortality in Cardiac Intensive Care Unit Patients with Pulmonary Hypertension.
     Am J Cardiol. 2025 Oct 11:S0002-9149(25)00625.
     PubMed    
     Abstract available
     
     

148. THAPA S, Sarkar P, Gaber MW, Barrios R, et al
     Adrenomedullin Overexpression Protects Mice from Experimental Bronchopulmonary Dysplasia and Associated Pulmonary Hypertension.
     Am J Physiol Lung Cell Mol Physiol. 2025 Oct 13. doi: 10.1152/ajplung.00234.2025
     PubMed    
     Abstract available
     
     

149. YOGESWARAN A, Hassoun PM, Saleh K, Funderich M, et al
     Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis.
     Am J Respir Crit Care Med. 2025;211:1855-1866.
     PubMed    
     Abstract available
     
     

150. GLADWIN MT, Kato GJ, Machado RF
     10-Year Longitudinal Study Clarifies Impact of Hemolysis and Pulmonary Hypertension on Patients with Sickle Cell Anemia.
     Am J Respir Crit Care Med. 2025 Oct 10. doi: 10.1164/rccm.202509-2289.
     PubMed    
     
     
     

151. SZWED P, Kurzyna P, Banaszkiewicz-Cyganik M, Kedzierski P, et al
     Impact of elevated Pulmonary Arterial Wedge Pressure on safety and efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension.
     Chest. 2025 Oct 18:S0012-3692(25)05620-X. doi: 10.1016/j.chest.2025.
     PubMed    
     Abstract available
     
     

152. KIM Y, Maroli G, Woodcock CC, Kim H, et al
     Deficiency of Smooth Muscle ADAR1 Exacerbates Vascular Remodeling and Pulmonary Hypertension.
     Circ Res. 2025 Oct 22. doi: 10.1161/CIRCRESAHA.125.326235.
     PubMed    
     Abstract available
     
     

153. VANHOOF B, Staal DP, Quarck RA, Van Langenhoven L, et al
     Tricuspid Regurgitation and Pulmonary Haemodynamics After Pulmonary Endarterectomy.
     Eur J Cardiothorac Surg. 2025;67:ezaf298.
     PubMed    
     Abstract available
     
     

154. ALESSI AW, Westphal JA, Masuodi B, Graur A, et al
     Safety of percutaneous thermal ablation of lung tumors in pulmonary hypertension.
     Eur J Cardiothorac Surg. 2025 Sep 25:ezaf312. doi: 10.1093.
     PubMed    
     Abstract available
     
     

155. KOVACS G, Zeder K, Olsson KM, Hoeper MM, et al
     Pulmonary vascular resistance to define severe pulmonary hypertension: cutting the Gordian knot.
     Eur Respir J. 2025;66:2501418.
     PubMed    
     
     
     

156. NAEIJE R, Chaouat A, Pinsky MR
     Reply to: Pulmonary vascular resistance to define severe pulmonary hypertension: cutting the Gordian knot.
     Eur Respir J. 2025;66:2501474.
     PubMed    
     
     
     

157. UYSAL OF, Hurst JR
     Pulmonary hypertension in COPD exacerbation: a transient storm with long-term consequences?
     Eur Respir J. 2025;66:2501508.
     PubMed    
     
     
     

158. RASTODER E, Sivapalan P, Hedsund C, Kamstrup P, et al
     Pulmonary pressure increases during acute exacerbation in COPD and clinical outcome.
     Eur Respir J. 2025;66:2500169.
     PubMed    
     Abstract available
     
     

159. EL-HINDI S
     Vardenafil vs. Sildenafil for the Treatment of Persistent Pulmonary Hypertension in Newborns.
     Indian J Pediatr. 2025 Oct 4. doi: 10.1007/s12098-025-05787.
     PubMed    
     
     
     

160. BERTOLETTI L, Escal J, Boucly A, Turquier S, et al
     Association Between Anticoagulant Therapy and Survival in Pulmonary Arterial Hypertension: A Registry Report and Updated Meta-Analysis.
     J Am Coll Cardiol. 2025;86:982-995.
     PubMed    
     Abstract available
     
     

161. ALFIREVIC A, Geube M, Mi J, Elgharably H, et al
     Early Effect of Pulmonary Thromboendarterectomy on Right Ventricular-to-Pulmonary Artery Coupling.
     J Cardiothorac Vasc Anesth. 2025;39:2989-2998.
     PubMed    
     Abstract available
     
     

162. ZHU M, Xu F, Zhu L, Chen Q, et al
     FAP Promotes Pulmonary Artery Hypertension via Activation of the PTEN/PI3K/Akt Pathway.
     J Cardiovasc Pharmacol. 2025 Jul 17. doi: 10.1097/FJC.0000000000001735.
     PubMed    
     Abstract available
     
     

163. ASGHAR U, Man HJ, McInnis M, Ladak AM, et al
     Endothelin-1 Overexpression in Pulmonary Endarterectomy Specimens of CTEPH patients is associated with Pulmonary Hypertension Development.
     J Heart Lung Transplant. 2025 Sep 25:S1053-2498(25)02274.
     PubMed    
     Abstract available
     
     

164. DARIE AM, Doi A, Levvey BJ, Shingles H, et al
     Lung transplantation for chronic thromboembolic pulmonary hypertension - a case series.
     J Heart Lung Transplant. 2025 Oct 7:S1053-2498(25)02305.
     PubMed    
     Abstract available
     
     

165. LAU EM, Gerges C
     Lung transplantation for chronic thromboembolic pulmonary hypertension (CTEPH): a treatment of last resort.
     J Heart Lung Transplant. 2025 Oct 15:S1053-2498(25)02324.
     PubMed    
     
     
     

166. MCLAUGHLIN VV, Hoeper MM, Badesch DB, Ghofrani HA, et al
     Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
     N Engl J Med. 2025 Sep 30. doi: 10.1056/NEJMoa2508170.
     PubMed    
     Abstract available
     
     

167. RIENGVIRODKIJ N, Taechikantaphat M, Ampapol P, Kovorakul T, et al
     Clinical improvement in canine pulmonary hypertension with Perna canaliculus oil (PCSO-524) add-on therapy: Effects on exercise tolerance and cough.
     PLoS One. 2025;20:e0333526.
     PubMed    
     Abstract available
     
     

168. SINNATAMBY T, LaBranche J, Farr-Jones M, Fenske T, et al
     Obstructive airway disorders affecting individuals with hereditary hemorrhagic telangiectasia: A database review.
     PLoS One. 2025;20:e0331690.
     PubMed    
     Abstract available